Jan 16
A team of surgeons in Oxford have used a pioneering new form of gene therapy to stop six of their patients going blind--and it’s hoped the technique could be used to treat blindness more generally.
     |
Nov 05
Glybera is a drug meant to fight a very rare disorder: Lipoprotein lipase deficiency ,(LPLD) which prevents patients from metabolizing certain fat enzymes in the blood . It does this by modifying a patient’s DNA, and the European Commission has approved it for public use and it will be on sale in mid-2013. That makes it the first human gene therapy drug to be approved for use in the West (China’s been doing gene therapy since 2003.)
By Ubergizmo. Related articles: HIV virus receives double blow from new gene therapy , These Jeans Are 20% Plastic Bottles and Food Trays,
Who's in charge here?
This is site is run by Sascha Endlicher, M.A., during ungodly late night hours. Wanna know more about him? Connect via Social Media by jumping to about.me/sascha.endlicher.